Grocery stores are finding private-label brands, whether generic or premium quality, increasingly profitable.

A drug maker tries to reassure investors that new strategies like diversifying research through partnerships will help the company rebound.

The European Union accused drug companies of adding billions of dollars to health care costs by delaying or blocking the sale of less-expensive generic medicines.

The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the United States until 2011.

The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the United States until 2011.

The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the U.S. until 2011.

A year-old Manhattan design and communications group generated interest by the mere choice of its name, and other items.

After a brand is discontinued, what’s left is a name and the memories in consumers’ minds. To make money, maybe those memories — real or imagined — are all you need.

Investigators are seeking to determine whether companies are blocking generics drugmakers from getting less-expensive medicines to market quickly.

The importance of brand in sales raises the question of the market’s future stability as sales of perfume, a product that has few cultural roots in China, have recently risen exponentially.